Denali Therapeutics Inc. (DNLI)
NASDAQ·Healthcare·Biotechnology
$21.16
-1.12%
Mkt Cap $3.54B
Analyst Ratings
Buy
16
Hold
0
Sell
0
Price Target (21 analysts)
$34.60
Range $26.00 – $41.00
Implied Upside
+63.5%
Consensus $34.60 vs current $21.16
NASDAQ·Healthcare·Biotechnology
$21.16
-1.12%
Mkt Cap $3.54B
Buy
16
Hold
0
Sell
0
Price Target (21 analysts)
$34.60
Range $26.00 – $41.00
+63.5%
Consensus $34.60 vs current $21.16